Trial intelligence / Profile preview

Nitroglycerin for retained placenta

2008-001346-92Phase 2Active

Sponsor
No sponsor
Start
Apr 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in retained placenta comparing Oxytocin + Nitromex with Oxytocin + placebo (2 arms). Primary endpoint: Placental detachment after treatment. Started Apr 2008; status: active.

02

Drugs

nitroglycerin
03

Conditions

retained placenta

Beyond the preview

Go deeper on 2008-001346-92.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-001346-92.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call